Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Propanol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 2/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.47 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.47 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.47 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | CES2 | O00748 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.40 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.40 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.40 |
| ▸ | HTR2A | P28223 | 1/20 | 0.40 |
| ▸ | HTR2C | P28335 | 1/20 | 0.40 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.40 |
| ▸ | HRH1 | P35367 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propanol SCHEMBL15063409 | 1.00 | FFAR3 (0.47) | FFAR3HDAC1HDAC2HDAC3HDAC8 | |
| Propanol SCHEMBL28546602 | 1.00 | FFAR3 (0.47) | FFAR3HDAC1HDAC2HDAC3HDAC8 | |
| Propanol SCHEMBL7166504 | 1.00 | — | — | |
| Propanol SCHEMBL9517847 | 1.00 | FFAR3 (0.47) | FFAR3HDAC1HDAC2HDAC3HDAC8 | |
| Propanol SCHEMBL28208511 | 0.96 | — | — | |
| Propanol SCHEMBL28213673 | 0.96 | — | — | |
| Acetic Acid SCHEMBL146128 | 0.88 | — | — | |
| Oxalic Acid SCHEMBL27555551 | 0.88 | FFAR3 (0.44) | FFAR3HDAC1HDAC2HDAC3HDAC8 | |
| Acetic Acid SCHEMBL31228715 | 0.88 | FFAR3 (0.54) | FFAR3HDAC1HDAC2HDAC3HDAC8 | |
| Propanol SCHEMBL27505467 | 0.87 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8920796-B2 | Adsorbent for oral administration, and agent for treating or preventing renal or liver disease | KUREHA CORPORATION (JP) | 2014-12-30 | — | — | US | disclosed |
| US-8865161-B2 | Adsorbent for an oral administration, and agent for treating or preventing renal or liver disease | KUREHA CORPORATION (JP) | 2014-10-21 | — | — | US | disclosed |
| EP-2637644-A1 | LISURIDE, TERGURIDE AND DERIVATIVES THEREOF FOR USE IN THE PROPHYLAXIS AND/OR TREATMENT OF FIBROTIC CHANGES | Sinoxa Pharma UG (DE) | 2013-09-18 | — | — | EP | disclosed |
| US-8440228-B2 | Adsorbent for an oral administration, and agent for treating or preventing renal or liver disease | KUREHA CORPORATION (JP) | 2013-05-14 | — | — | US | disclosed |
| EP-2550959-A1 | Lisuride, terguride and derivatives of same for use in the prevention and/or treatment of fibrotic changes | Sinoxa Pharma (DE) | 2013-01-30 | — | — | EP | disclosed |
| US-20120244195-A1 | ADSORBENT FOR AN ORAL ADMINISTRATION, AND AGENT FOR TREATING OR PREVENTING RENAL OR LIVER DISEASE | KUREHA CORPORATION (JP) | 2012-09-27 | — | — | US | disclosed |
| WO-2012062676-A1 | LISURIDE, TERGURIDE AND DERIVATIVES THEREOF FOR USE IN THE PROPHYLAXIS AND/OR TREATMENT OF FIBROTIC CHANGES | SINOXA PHARMA UG (DE) | 2012-05-18 | — | — | WO | disclosed |
| US-20080081073-A1 | Surface treated and oxidized spherical activated carbon prepared from crosslinked vinyl resin, ion-exchange resin, or pitch; adsorbs large amount of toxins during retention period in an intestine; reduction of urinary protein excretion | KUREHA CORPORATION (JP) | 2008-04-03 | — | — | US | disclosed |
| EP-1525886-B1 | Absorbent for oral administration, and agent for treating or preventing renal or liver disease | KUREHA CORP (JP) | 2008-03-12 | — | — | EP | disclosed |
| US-20080044477-A1 | Adsorbent for an Oral Administration, and Agent for Treating or Preventing Renal or Liver Disease | KUREHA CORPORATION (JP) | 2008-02-21 | — | — | US | disclosed |
| US-20080031972-A1 | Process For Manufacturing Spherical Activated Carbon | KUREHA CORPORATION (JP) | 2008-02-07 | — | — | US | disclosed |
| EP-1748031-A1 | METHOD FOR PRODUCING SPHERICAL ACTIVATED CARBON | Kureha Corporation (JP) | 2007-01-31 | — | — | EP | disclosed |
| EP-1745793-A1 | ADSORBENT FOR ORAL ADMINISTRATION, THERAPEUTIC OR PREVENTIVE AGENT FOR KIDNEY DISEASE, AND THERAPEUTIC OR PREVENTIVE AGENT FOR LIVER DISEASE | Kureha Corporation (JP) | 2007-01-24 | — | — | EP | disclosed |
| EP-1745792-A1 | ADSORBENT FOR ORAL ADMINISTRATION, PREVENTIVE OR REMEDY FOR KIDNEY DISEASE AND PREVENTIVE OR REMEDY FOR LIVER DISEASE | Kureha Corporation (JP) | 2007-01-24 | — | — | EP | disclosed |
| US-20050112114-A1 | Surface treated active carbon; controlling particle sizes, porosity | KUREHA CHEMICAL INDUSTRY CO., LTD. | 2005-05-26 | — | — | US | disclosed |
| EP-1525886-A1 | Absorbent for oral administration, and agent for treating or preventing renal or liver disease | Kureha Chemical Industry Co., Ltd. (JP) | 2005-04-27 | — | — | EP | disclosed |